NOT-AG-17-002: Notice of NIA's Participation in PA-17-109, "Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)"

Notice of NIA's Participation in PA-17-109, "Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)"

Notice Number: NOT-AG-17-002

Key Dates
Release Date: January 30, 2017

Related Announcements
PA-17-109

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Aging (NIA) is participating in PA-17-109, "Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)."

The following changes have been made to reflect NIA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Cancer Institute (NCI)
National Institute on Aging (NIA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.394, 93.866

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Erica S. Breslau, Ph.D., M.P.H.,
National Cancer Institute (NCI)
Telephone: 240-276-6773
Email: [email protected]

Marcel E. Salive, M.D., M.P.H.
National Institute on Aging (NIA)
Telephone: 301-496-5278
Email: [email protected]

Financial/Grants Management Contact(s)

Carol Perry
National Cancer Institute (NCI)
Telephone: 240-276-6282
Email: [email protected]

Lesa McQueen, M.Sc.
National Institute on Aging (NIA)
Telephone: 301-402-7736
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Marcel E. Salive, M.D., M.P.H.
National Institute on Aging (NIA)
Telephone: 301-496-5278
Email: [email protected]